Pharma in Healthcare
Pharma in Healthcare
Cell line development market to reach $8.95 billion by 2031 with Gene & Cell Therapy manufacturing growing at 10.88%
According to Mordor Intelligence, the global cell line development market is projected to grow from USD 4.97 billion in 2025 to USD 5.48 billion in 2026, and is expected to...
Pharma in Healthcare
Romaco Group appoints Nicola Magriotis as Chief Sales Officer
The advisory board of Romaco Holding GmbH has appointed Nicola Magriotis as Chief Sales Officer (CSO) of the Romaco Group. By creating this new managerial...
Pharma in Healthcare
New report finds FDA costs soaring and drug rejections rising
The Taxpayers Protection Alliance released a report, called Blocking Breakthroughs: Delays and Denials at the FDA, that highlights the many issues with the Food and Drug...
Pharma in Healthcare
FDA approves Novo Nordisk’s Awiqli, the first and only once-weekly basal insulin treatment for adults with type 2 diabetes
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and only once-weekly, long-acting basal insulin,...
Pharma in Healthcare
Global paediatric consumer health market to reach US$254 billion by 2032 amid growing focus on child wellness and nutrition
According to the latest market study published by Vyansa Intelligence, the global paediatric consumer health market is projected to grow at a CAGR of around 5%...
Pharma in Healthcare
The evolution of patient expectations in medical aesthetics
Allergan Aesthetics, an AbbVie company and global leader in medical aesthetics, has announced new global consumer research highlighting how patient expectations in medical aesthetics...
Pharma in Healthcare
Global medtech CDMO market grows to $96.5b in 2025 as Pharma-Medtech convergence emerges as a defining accelerator
Alira Health, a global healthcare consulting and research organisation, today released its sixth annual report on the state of the contract development and manufacturing...
Pharma in Healthcare
Middle East conflict disrupts pharma air routes threatening cancer drug supply
The Middle East is a significant market for global drugmakers, and any prolonged instability could have escalating and cascading effects, not only delaying supplies...
- Advertisement -
- Advertisement -
Latest stories
© 2026 Pharma Press Publishing.